| Cub Pharmacy #1913/621 | |
| 2850 26th Ave S, Minneapolis, Minnesota 55406 | |
| (612) 721-5840 |
| Name | Cub Pharmacy #1913/621 |
|---|---|
| Organization Name | Supervalu Pharmacies Inc |
| Location | 2850 26th Ave S, Minneapolis, Minnesota 55406 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (612) 721-5840 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Nearly 30 percent of women failed to pick up their bisphosphonate prescriptions, a medication that is most commonly used to treat osteoporosis and similar bone diseases, according to a Kaiser Permanente study published this week in the journal Osteoporosis International.
A multi-centre phase II clinical trial for a pioneering new surgical technique has started in the UK, jointly funded by Samantha Dickson Brain Tumour Trust and Cancer Research UK.
Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.
EP Global Communications, Inc., makes the following announcement: In a first for the company, one of EPGL's advanced technologies has been selected by a multi-billion dollar, NYSE publicly traded industry leader for development and integration into new products.
› Verified 1 days ago
| NPI Number | 1497860530 |
| Organization Name | SUPERVALU PHARMACIES INC |
| Doing Business As | CUB PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2850 26th Ave S, Minneapolis, MN 55406 |
| Phone Number | 612-721-5840 |
News Archive
Nearly 30 percent of women failed to pick up their bisphosphonate prescriptions, a medication that is most commonly used to treat osteoporosis and similar bone diseases, according to a Kaiser Permanente study published this week in the journal Osteoporosis International.
A multi-centre phase II clinical trial for a pioneering new surgical technique has started in the UK, jointly funded by Samantha Dickson Brain Tumour Trust and Cancer Research UK.
Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.
EP Global Communications, Inc., makes the following announcement: In a first for the company, one of EPGL's advanced technologies has been selected by a multi-billion dollar, NYSE publicly traded industry leader for development and integration into new products.
› Verified 1 days ago
News Archive
Nearly 30 percent of women failed to pick up their bisphosphonate prescriptions, a medication that is most commonly used to treat osteoporosis and similar bone diseases, according to a Kaiser Permanente study published this week in the journal Osteoporosis International.
A multi-centre phase II clinical trial for a pioneering new surgical technique has started in the UK, jointly funded by Samantha Dickson Brain Tumour Trust and Cancer Research UK.
Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.
EP Global Communications, Inc., makes the following announcement: In a first for the company, one of EPGL's advanced technologies has been selected by a multi-billion dollar, NYSE publicly traded industry leader for development and integration into new products.
› Verified 1 days ago
Mesa Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2603 Bloomington Ave, Minneapolis, Minnesota 55407 Phone: (612) 501-5009 | |
Alina Health System Type: Community/Retail Pharmacy Location: 913 E 28th Street, Minneapolis, Minnesota 55407 Phone: (612) 863-5370 | |
Allina Health System Type: Clinic Pharmacy Location: 920 E 28th St, Minneapolis, Minnesota 55407 Phone: (612) 775-3100 | |
Cvs Pharmacy #07172 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2001 Nicollet Ave, Minneapolis, Minnesota 55404 Phone: (612) 872-2656 | |
Cvs Pharmacy #05996 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3655 Central Ave Ne, Minneapolis, Minnesota 55418 Phone: (612) 789-2460 |